Weight loss drugs from Eli Lilly and Novo Nordisk
A Zepbound injection pen from Eli Lilly & Co., March 28, 2024. Bloomberg | Bloomberg | Getty Images Do you…
A Zepbound injection pen from Eli Lilly & Co., March 28, 2024. Bloomberg | Bloomberg | Getty Images Do you…
Zoom iconArrows pointing outwards Direct-to-consumer healthcare startup Ro on Tuesday launched a new, free tool to help patients determine whether…
Investors want to know if Eli Lilly is experiencing the same pricing pressures on its blockbuster weight-loss drug Zepbound that…
An injection pen for Eli Lilly's weight-loss drug Zepbound is displayed in New York City, Dec. 11, 2023. Brendan McDermid…
An Eli Lilly & Co. Zepbound injection pen is prepared in the Brooklyn borough of New York, U.S., on Thursday,…
Slimming syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Image…
A box of the drug Victoza, manufactured by Novo Nordisk Pharmaceutical, sits on a pharmacy counter in Provo, Utah, January…
The lucrative market for weight-loss drugs won’t be a duopoly forever. With billions at stake, that’s been a virtual guarantee…
Weight-loss drugs have sparked investor interest and shaken up other sectors over the past year. Novo Nordisk and Eli Lilly…
Weight loss drug concept. Cr | Istock | Getty Images Actions of Viking Therapeutics rose more than 20% on Thursday…